Baxter International Inc. (NYSE:BAX) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Baxter International Inc. (NYSE:BAXGet Rating) have been assigned a consensus rating of “Hold” from the fifteen analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $77.69.

A number of brokerages recently issued reports on BAX. Cowen reduced their price target on Baxter International from $95.00 to $70.00 in a research report on Friday, July 29th. Wells Fargo & Company downgraded Baxter International from an “overweight” rating to an “equal weight” rating and set a $71.00 price target on the stock. in a research report on Friday, June 24th. Cowen reduced their price target on Baxter International from $95.00 to $70.00 in a research report on Friday, July 29th. Deutsche Bank Aktiengesellschaft reduced their price target on Baxter International from $99.00 to $69.00 in a research report on Friday, July 29th. Finally, Stifel Nicolaus reduced their target price on Baxter International from $85.00 to $75.00 in a report on Monday, July 18th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of BAX. Neuberger Berman Group LLC raised its position in Baxter International by 2,202.6% during the 1st quarter. Neuberger Berman Group LLC now owns 1,650,719 shares of the medical instruments supplier’s stock worth $128,029,000 after purchasing an additional 1,579,029 shares during the last quarter. Geode Capital Management LLC grew its holdings in Baxter International by 6.6% during the 4th quarter. Geode Capital Management LLC now owns 8,719,597 shares of the medical instruments supplier’s stock worth $746,523,000 after acquiring an additional 540,182 shares during the period. Cooke & Bieler LP grew its holdings in Baxter International by 19.2% during the 2nd quarter. Cooke & Bieler LP now owns 1,295,745 shares of the medical instruments supplier’s stock worth $83,226,000 after acquiring an additional 208,650 shares during the period. Tobam grew its holdings in Baxter International by 429.0% during the 1st quarter. Tobam now owns 239,478 shares of the medical instruments supplier’s stock worth $18,569,000 after acquiring an additional 194,205 shares during the period. Finally, BNP Paribas Arbitrage SA grew its holdings in Baxter International by 140.6% during the 1st quarter. BNP Paribas Arbitrage SA now owns 327,977 shares of the medical instruments supplier’s stock worth $25,431,000 after acquiring an additional 191,637 shares during the period. 84.69% of the stock is owned by institutional investors.

Baxter International Price Performance

Baxter International stock opened at $58.97 on Friday. Baxter International has a 12 month low of $54.45 and a 12 month high of $89.70. The stock’s 50 day moving average is $60.78 and its 200-day moving average is $69.59. The company has a current ratio of 2.01, a quick ratio of 1.33 and a debt-to-equity ratio of 1.83. The company has a market capitalization of $29.70 billion, a price-to-earnings ratio of 29.49, a PEG ratio of 2.10 and a beta of 0.60.

Baxter International (NYSE:BAXGet Rating) last posted its earnings results on Thursday, July 28th. The medical instruments supplier reported $0.87 EPS for the quarter, meeting the consensus estimate of $0.87. Baxter International had a return on equity of 21.75% and a net margin of 7.12%. The company had revenue of $3.75 billion for the quarter, compared to the consensus estimate of $3.88 billion. During the same quarter in the prior year, the business earned $0.80 earnings per share. The firm’s revenue for the quarter was up 20.9% on a year-over-year basis. Equities research analysts expect that Baxter International will post 3.63 EPS for the current year.

Baxter International Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, October 3rd. Investors of record on Friday, September 2nd will be given a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 1.97%. The ex-dividend date of this dividend is Thursday, September 1st. Baxter International’s dividend payout ratio is currently 58.00%.

About Baxter International

(Get Rating)

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.

Featured Articles

Analyst Recommendations for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.